Literature DB >> 26856220

Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.

Yong Liu1, Ji-Yan Chen2, Yong Huo3, Jun-Bo Ge4, Ying Xian5, Chong-Yang Duan6, Shi-Qun Chen7, Wei Jiang5, Ping-Yan Chen6, Ning Tan1.   

Abstract

Adequate hydration is recommended for acute ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) to prevent contrast-induced nephropathy (CIN). However, the optimal hydration regimen has not been well established in these high-risk patients. The objective of this study is to evaluate the efficacy of a preprocedural loading dose plus postprocedural aggressive hydration with normal saline guided by the left ventricular end-diastolic pressure (LVEDP) compared with general hydration for CIN prevention. The ATTEMPT study is a multicenter, open-label, investigator-driven, randomized controlled trial in China. Approximately 560 patients with STEMI undergoing primary PCI will be randomized (1:1) to receive either periprocedural general hydration (control group) or aggressive hydration (treatment group). Patients in the control group receive periprocedural general hydration with ≤500 mL normal saline (within 6 hours) at a normal rate (0.5 or 1 mL/kg · h). Patients in the treatment group receive a preprocedural loading dose (125/250 mL) of normal saline within 30 minutes and intravenous hydration at a normal rate until LVEDP is available, followed by postprocedural aggressive hydration guided by LVEDP for 4 hours and then continuous intravascular hydration at the normal rate until 24 hours after PCI. The primary end point is CIN, defined as a >25% or 0.5-mg/dL increase in serum creatinine from baseline during the first 48 to 72 hours after procedure. The ATTEMPT study has the potential to identify optimal hydration regimens for STEMI patients undergoing PCI.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26856220     DOI: 10.1016/j.ahj.2015.10.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.

Authors:  Armin Marashizadeh; Hamid Reza Sanati; Parham Sadeghipour; Mohamad Mehdi Peighambari; Jamal Moosavi; Omid Shafe; Ata Firouzi; Ali Zahedmehr; Mohsen Maadani; Farshad Shakerian; Reza Kiani; Bahram Mohebbi; Mohammad Javad Alemzadeh-Ansari; Reza Tahvili; Batoul Naghavi
Journal:  Int Urol Nephrol       Date:  2019-07-22       Impact factor: 2.370

2.  Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.

Authors:  Weijie Bei; Hualong Li; Kaiyang Lin; Kun Wang; Shiqun Chen; Xiaosheng Guo; Yong Liu; Ning Tan; Jiyan Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

3.  The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale.

Authors:  Alhasan Mujtaba; Mohammed A Taher; Mazin A Hazza; Hassan M Al-Rubaye; Asaad H Kata; Hamid AbdulWahab; AbdulAmeer AbdulBari; Hayder K AlRubay
Journal:  Cardiol Ther       Date:  2018-05-21

4.  The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study.

Authors:  Wei Guo; Feier Song; Shiqun Chen; Li Zhang; Guoli Sun; Jin Liu; Jiyan Chen; Yong Liu; Ning Tan
Journal:  Trials       Date:  2020-06-24       Impact factor: 2.279

5.  Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yong Liu; Daqing Hong; Amanda Ying Wang; Rui Guo; Brendan Smyth; Jin Liu; Guoli Sun; Shiqun Chen; Ning Tan; Meg Jardine; David Brieger; Ahmed Shaman; Shariful Islam; Jiyan Chen; Martin Gallagher
Journal:  BMC Cardiovasc Disord       Date:  2019-04-08       Impact factor: 2.298

6.  Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial.

Authors:  Feier Song; Guoli Sun; Jin Liu; Ji-Yan Chen; Yibo He; Liwei Liu; Yong Liu
Journal:  Trials       Date:  2019-05-27       Impact factor: 2.279

7.  Could sST2 Predict Contrast-Induced Nephropathy in ST-Segment Elevation Myocardial Infarction?

Authors:  Ahmet Avcı; Mustafa Umut Somuncu; Murat Can; Ferit Akgul
Journal:  Int J Gen Med       Date:  2020-11-27

8.  Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.

Authors:  Guang Ma; Min Li; Wei Teng; Zhaohui He; Xiaojv Zhai; Zhenhua Xia
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

9.  Statistical analysis plan for aggressive hydraTion in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT) study.

Authors:  Jin Liu; Zhaodong Guo; Li Lei; Guoli Sun; Yibo He; Feier Song; Jiyan Chen; Ning Tan; Shiqun Chen; Yong Liu
Journal:  Ann Transl Med       Date:  2020-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.